key: cord-0998986-78lshz58
authors: Biagioli, Michele; Marchianò, Silvia; Roselli, Rosalinda; Giorgio, Cristina Di; Bellini, Rachele; Bordoni, Martina; Gidari, Anna; Sabbatini, Samuele; Francisci, Daniela; Fiorillo, Bianca; Catalanotti, Bruno; Distrutti, Eleonora; Carino, Adriana; Zampella, Angela; Costantino, Gabriele; Fiorucci, Stefano
title: Discovery of a AhR flavonoid agonist that counter-regulates ACE2 expression in rodent models of inflammation and attenuates ACE2-SARS-CoV2 interaction in vitro
date: 2021-02-24
journal: bioRxiv
DOI: 10.1101/2021.02.24.432203
sha: 62a216908e18331da6417422a353f9d61d96fe19
doc_id: 998986
cord_uid: 78lshz58

The severe acute respiratory syndrome (SARS)-CoV-2, a newly emerged coronavirus first identified in 2019, is the pathogenetic agent od Corona Virus Induced Disease (COVID)19. The virus enters the human cells after binding to the angiotensin converting enzyme (ACE) 2 receptor in target tissues. ACE2 expression is induced in response to inflammation. The colon expression of ACE2 is upregulated in patients with inflammatory bowel disease (IBD), highlighting a potential risk of intestinal inflammation in promoting viral entry in the human body. Because mechanisms that regulate ACE2 expression in the intestine are poorly understood and there is a need of anti-SARS-CoV2 therapies, we have settled to investigate whether natural flavonoids might regulate the expression of ACE2 in intestinal models of inflammation. The results of these studies demonstrated that pelargonidin, a natural flavonoid bind and activates the Aryl hydrocarbon Receptor (AhR) in vitro and reverses intestinal inflammation caused by chronic exposure to high fat diet or to the intestinal braking-barrier agent DSS in a AhR-dependent manner. In these two models, development of colon inflammation associated with upregulation of ACE2 mRNA expression. Colon levels of ACE2 mRNA were directly correlated with TNFα mRNA levels. In contrast to ACE2 the angiotensin 1-7 receptor MAS was downregulated in the inflamed tissues. Molecular docking studies suggested that pelargonidin binds a fatty acid binding pocket on the receptor binding domain of SARS-CoV2 Spike protein. In vitro studies demonstrated that pelargonidin significantly reduces the binding of SARS-CoV2 Spike protein to ACE2 and reduces the SARS-CoV2 replication in a concentration-dependent manner. In summary, we have provided evidence that a natural flavonoid might hold potential in reducing intestinal inflammation and ACE2 induction in the inflamed colon in a AhR-dependent manner.

The coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused severe acute respiratory syndrome (SARS)-CoV-2, a newly emerged coronavirus first identified in the city of Wuhan in China in December 2019 [1] . The SARS-CoV2 virus entry into host cells is mediated by interaction between the spike (S) glycoprotein, that assembly into an homotrimeric complex protruding from the viral surface, with the angiotensin-converting enzyme 2 (ACE2) [2] . The spike glycoprotein comprises two functional subunits: the S1 subunit contains a specific motif, the receptorbinding domain (RBD), that is responsible for binding to ACE2, while the S2 subunit is essential for fusion of the viral and cellular membranes [2] Thus, targeting the interaction of spike's RBD with ACE2 might hold potential for the treatment of COVID 19. Accordingly, several agents that target the SARS-CoV2/ACE2 interaction, including several monoclonal antibodies, have been identified and tested clinically.

Following a similar approach, it has been suggested that modulation of ACE2 expression could also be of interest in reducing SARS-CoV2 entry in target cells [2] [3] [4] [5] [6] [7] .

The expression of ACE2 vary greatly among human tissues. In the normal lung, ACE2 mRNA is mainly expressed by type I and II alveolar (AT1 and AT2) epithelial cells and endothelial cells [8, 9] . However, it has been shown that the expression of ACE2 in the lung increases in response to inflammation or exposure to interferon IFNγ [10] . In normal individual, ACE2 mRNA and protein are highly expressed in the gastrointestinal system, in particular in the duodenum, jejunum, ileum, and colon, although the functional role of this peptidase in intestinal epithelial cells remains portly elucidated [11] . Furthermore, similarly to the lung, the intestinal expression of ACE2 is modulated in response to intestinal inflammation in inflammatory bowel disease (IBD) in a phenotype dependent manner [12] . More specifically, while expression of Ace2 is reduced in the ileum of patients with active Crohn disease, an elevated colonic expression of ACE2 mRNA has been reported in ulcerative colitis patients with active inflammation and severe disease [13] [14] [15] . Since the colonic ACE2 levels normalize after anti-cytokine therapy and the anti-cytokine therapy associates with reduced morbidity of IBD patients from COVID19, these data establish a relation between the levels of colonic ACE2 expression and beneficial effects exerts by anticytokine therapies. Moreover, the evaluation of SECURE-IBD registry (available http://www.covidibd.org.) suggest that patients with IBD are under-represented in those diagnosed with COVID-19 compared to the general populations [16] . Despite these data raise interest on ACE2 as potential target in COVID19 and IBD, the mechanisms involved in ACE2 regulation in the intestine are only partially understood. Further on, it is unclear whether ACE2 expression could be modulated with dietary factors that might have also utility in reducing inflammation.

The aryl hydrocarbon receptor (AhR) is a ligand-activated nuclear receptor that belongs to the basic helix-loop-helix (bHLH)/PerARNT-Sim (PAS) superfamily.

Although AhR was originally described as a xenobiotics sensor, it is now well established that dietary/intestinal microbiota metabolites represent the physiological ligands [17] . Similarly, to other nuclear receptors, in the absence of a ligand, AhR resides in cytoplasm as a component of a chaperone complex [18] . The AhR is widely expressed by cells of innate/adaptive immunity [19] but it is also expressed at high levels by intestinal epithelial cells where it is essential for maintaining the integrity of the intestinal barrier and therefore for regulating the inflammatory state of the gastrointestinal tract. [20, 21] .

Pelargonidin is a water soluble anthocyanidin that is widely diffuse in nature as glycosylated derivatives and that is responsible for the red/orange colours of berries such as raspberries and strawberries, as well as blueberries and blackberries [22] .

While, similarly to other anthocyanins, pelargonidin is thought to be beneficial for human health [23] [24] [25] , controversies exist over the doses needed to reach these effects, along with poor systemic bioavailability and unclear mechanism(s) of action.

In a previous study we have shown that the natural pelargonidin function as AhR ligand in vitro and attenuates intestinal inflammation in AhR-dependent manner [26] . In the present study we have investigated the potential of the natural pelargonidin in regulating ACE2 expression in colon in models of intestinal inflammation caused by exposure of wild type and AhR -/mice to a high caloric intake and intestinal irritants. The results of these studies show that not only a dietary agent might regulate the expression of the ACE2 in the colon but also inhibit the interaction of SARS-CoV2's spike protein with ACE2, providing a potentially useful clues in the prevention and treatment of COVID19.

For AhR-mediated transactivation, HepG2 cells were plated at 7.5 × 10 4 

Spleens were collected from AhR + / + and AhR -/mice. Spleens were homogenized and then red blood cell lysis was performed using a hypotonic solution. After cell count, the cell pellet was resuspended at a concentration of 10 8 / mL, to proceed to the positive selection of Cd11b + cells. In particularly, macrophages were purified using Cd11b microbeads (130-049-601) by Miltenyi Biotec, according to the manufacturer's instructions. Subsequently the selected macrophages have been plated at a concentration of 500.000/mL and were activated with LPS (5 ng / mL, Sigma-Aldrich L2880) in combination with IFN-γ (20ng / mL, eBioscience, San Diego, CA, USA) for 16 hours alone or in addition to Pelargonidin (20 µM) for gene expression profile analysis.

All animal care and experimental procedures complied with the guidelines of Animal To reproduce a mouse model of Acute Colitis a 2,4,6-trinitrobenzenesulfonic acid (Sigma Chemical Co, St Louis, MO) (TNBS)-colitis model is used as previously described [27] . Briefly, according to this 8-10 weeks old male mice C57BL/6J wildtype and Ahr +/+ and Ahr -/on C57BL/6J genetic background were administrated.

Briefly, mice were fasted for 12 h overnight (Day -1). The next day (Day 0), mice were sedated by administration of Zoletil at a dose of 50 mg/Kg of body weight. Then a 3.5 F = 11.55 mm catheter was inserted into the colon such that it was up to 4 cm from the anus and 1 mg of TNBS in 50% ethanol administered via the catheter into the colon lumen using a 1 mL syringe (injection volume of 100 μL). Control mice received 50% ethanol alone. Pelargonidins were administered by oral gavage (1, 5 or 10 mg/kg) daily from day 0 to the 4 day, that is the day of sacrifice. The severity of colitis was scored daily for each mouse by assessing body weight, the fecal occult blood, and stool consistency. Each parameter was scored from 0 to 4 and the sum represents the Colitis Disease Activity Index (CDAI). The scoring system was as follows: Percent of body weight loss: None = 0; 1-5% = 1; 5-10% = 2; 10-20% = 3; >20% = 4. Stool consistency: Normal = 0; soft but still formed = 1; very soft = 2; diarrhea = 3; liquid stools that stick to the anus or anal occlusion = 4. Fecal blood: None = 0; visible in the stool = 2; severe bleeding with fresh blood around the anus and very present in the stool = 4. On day 4, surviving mice were sacrificed, blood samples collected by facial vein, and the colon excised, measured length and weight, and evaluated for macroscopic damage.

To investigate the effects of Pelargonidins in a mouse model of NASH, 10-12 weeks old C57BL/6 male mice, Ahr wild type (Ahr +/+ ) and their congenic littermates AhR null mice (Ahr -/-) were fed a high fat diet containing 59 KJ% fat plus 1% cholesterol, w/o sugar (ssniff® EF R/M acc. D12330 mod. 22.7 ME/Kg) and fructose in drinking water (42 g/L) for 8 weeks as previously described [28] . Food intake was valued as the difference of weight between the provided and the remnant amount of food at 2-day intervals. The food was provided as pressed pellets and the residual spillage was not considered. After 8 days, Ahr +/+ and Ahr −/− HFD-F mice were randomized to receive HFD-F alone or plus Pelargonidin (5 mg/Kg/die) by oral gavage for remaining 7 weeks.

On the sacrifice day, fed mice were deeply anesthetized with Zoletil at a dose of 50 mg/Kg and sacrificed before 12 AM. Thus, blood, liver, small intestine, colon, spleen, epididymal adipose tissue (eWAT), brown adipose tissue (BAT) and gastrocnemius were collected. The abdominal circumference (AC) (immediately anterior to the forefoot), body weight, and body length (nose-to-anus or nose-anus length), were measured in anaesthetized mice at the day of sacrifice. The body weight and body length were used to calculate the Body mass index (BMI) (=body weight (g)/length 2 (cm 2 )).

Intestinal permeability test was performed using fluorescein isothiocyanate conjugated dextran (FITC-dextran) (Sigma-Aldrich, St. Louis, MO, USA, catalog number: FD4). FITC-dextran was dissolved in PBS at a concentration of 100 mg/mL.

The evening before the test day mice were fasted overnight. In the next morning, after weighing each mouse, FITC was administered to each one at a dose of 44 mg/100 g of body weight by oral gavage. After 4 hours, the mice were anesthetized by inhalation of isoflurane and 300-400 μl of blood collected from the facial vein in microtubes containing EDTA. Blood was stored in the dark. Once blood has been collected from all the mice, microtubes were processed to separate the serum. For analysis, serum was diluted with an equal volume of PBS. The concentration of FITC in serum was determined by spectrophoto fluorometry with an excitation of 485 nm and an emission wavelength of 528 nm using as standard serially diluted FITCdextran (0, 125, 250, 500, 1,000, 2,000, 4,000, 6,000, 8,000 ng/ml). Serum from mice not administered with FITC-dextran was used to determine the background.

Colon sample (2-3 cm up anus) were first fixed in 10% formalin, embedded in paraffin, 

Caco-2 cells, a human intestinal epithelial cell line (Sigma-Aldrich) was grown at 37 °C in D-MEM containing 10% FBS, 1% l-glutamine, and 1% penicillin/streptomycin. Cells were regularly passaged to maintain exponential growth. Caco-2 cells were classically activated with TNF-α 100 ng/ml for 24 h alone or in combination with pelargonidin (5, 10, and 20 µM) for the analysis of expression of several genes.

Pelargonidin at different concentrations (1-10-20-50 µM) was tested using the ACE2: SARS-CoV-2 Spike Inhibitor Screening Assay Kit (BPS Bioscience Cat. number #79936) according to the manufacturer's instructions. Briefly, we have thawed ACE2 protein on ice and diluted to 1 μg/ml in PBS. We have used 50 μL of ACE solution to coat a 96-well nickel-coated plate (1 hour). The plate was washed 3 times and incubated for 10 min with a Blocking Buffer. Next, 10 μL of inhibitor solution containing the pelargoidin was added to wells and incubated for 1 h at room temperature with slow shaking. For the "Positive Control" and "Blank," 10 μL of inhibitor buffer (5% DMSO solution) were used. After the incubation (1 hour), SARS-CoV-2 Spike (RBD)-Fc was thawed on ice and diluted to 0.25 ng/μL (~5 nM) in Assay Buffer 1; 5 nM Spike protein was added to each well, except to the blank. The reaction was incubated for 1 h at room temperature, with slow shaking. After 3 washes and incubation with a Blocking Buffer (10 min), we have treated the plate with an Antimouse-Fc-HRP and the plate was incubated for 1 h at room temperature with slow shaking. Finally, HRP substrate was added to the plate to produce chemiluminescence, which was measured using FluoStar Omega microplate reader.

To confirm the validity of the assay used in this study, remnants of plasma samples 

The experiments were performed in Biological Safety Level 3 (BSL-3) virology laboratory of "Santa Maria della Misericordia" Hospital, Perugia, Italy. The SARS-CoV-2 strain was isolated as previously described [30] . For viral propagation, Vero E6 cell line was maintained in Eagle minimal essential medium (MEM) supplemented with 10% foetal bovine serum (FBS) and 100 U/mL penicillin-streptomycin solution.

After isolation, SARS-CoV-2 titer was determined by Median Tissue Culture Infectious Dose (TCID50) endpoint dilution and stock aliquots were stored at -80°C.

The stock virus titer was 4.22 ×107 TCID50/mL.

Vero E6 cells (20, 

Supernatants viral titer was determined by plaque assay as previously described [31] , with some modifications. Vero E6 cells (600,000 cells/well) were seeded in a 6-well plate and incubated at 37°C with 5% CO2 for 24 h. After incubation, the medium was removed and cells were infected with 500 µl of ten-fold serial dilution of supernatant previously obtained, rocking the plates every fifteen minutes. In the meanwhile, the overlay medium (complete medium with agar 0.1%) was prepared and maintained in a 50°C water bath. After 1 h of infection, the overlay medium (2 mL) was poured into each well and the plates incubated for 3 days. Finally, the overlay was discarded, cells were fixed for 30 min with 4% formalin and stained with 0.5% crystal violet. Viral titer was determined as plaque-forming units per mL, considering wells with plaques ranging from 2 to 100. For each pool of supernatants, plaque-reduction assay was performed in duplicate. 

We have first investigated whether the natural pelargonidin exerted agonistic effects on AhR. The activity of pelargonidin was evaluated in a luciferase reporter assay using HepG2 cells, transiently transfected with a AhR reporter gene cloned upstream to the luciferase. HepG2 were incubated with 5 nM TCDD, an AhR agonist as a control, or vehicle (0.1% v/v DMSO) in the presence of the pelargonidin (10-50 µM) for 18 h. As shown in Figure 1A , pelargonidin was found effective in transactivating the AhR; furthermore, in a concentration-response curve analysis, we found that pelargonidin transactivated AhR with a relative potency, expressed as EC50, of 12 µM ( Figure 1B ).

restore Ace2 expression suggest that 5 mg/kg of pelargonidin was fully effective in reversing signs of intestinal inflammation we used this dose to further investigate the mechanism of action of pelargonidin on intestinal immunity. For this purpose, we induced a colon inflammation by administering TNBS to Ahr +/+ and Ahr -/mice. As shown previously by us and others, Ahr -/mice are very susceptible to the TNBS colitis with high mortality rate [26] . In our experimental set we found a mortality rate of 80% in the Ahr knock-out group and therefore it was not possible to further investigate in this strain (data not shown). In wild-type mice, however, the severity of wasting disease and intestinal inflammation induced by TNBS was reversed by treatment with pelargonidin as measured by lower body weight lost, lower CDAI and by assessing the macroscopic and microscopic feature of the colon (Figure 3A-C) . In this mouse model of colitis, we found a much greater upregulation of pro-inflammatory cytokine expression than that found in the mouse model of HFD-F ( Figure 3E -I); Il-1β was upregulated ≈20 times in the colon of TNBS-treated mice in comparison to ≈2 folds in mice subjected to HFD-F compared to naïve mice ( Figure 3G ). Furthermore, a five fold increase in Tnf-α mRNA was detected in the TNBS model in comparison to mice fed a HFD-F ( Figure 3H ). These changes were consistent with a very robust increase with in Ace2 gene expression (7-fold in comparison to wild type mice). Changes in Ace2 expression associated with robust decrease in Mas expression ( Figure 3E , F).

Administering TNBS mice with pelargonidin reversed this patter by up-regulating the expression of Tgf-β and simultaneously decreasing the expression of both Il-1β

and Tnf-α ( Figure 3G -I). The anti-inflammatory effect exerted by pelargonidin also resulted in a strong reduction of Ace2 mRNA expression. The correlation analysis between Il-1β/Ace2 and Tnf-α/Ace2 confirmed that there was a statistical correlation between the expression of the two pro-inflammatory cytokines and Ace2 (Il-1β/Ace2 P value = 0.0244; Tnf-α/Ace2 P value < 0.0001). Again, there was a closer correlation between the expression of Ace2 and that of Tnf-α (Il-1β/Ace2 R squared = 0.1867; Tnfα/Ace2 R squared = 0.7695).

Due to the inability to analyze the effects of pelargonidin treatment in the colitis model in Ahr -/mice for the high mortality, to investigate whether the immunomodulatory effect exerted by pelargonidin was mediated by binding on AHR, we tested the compound on murine macrophages purified from the spleen of Ahr +/+ and Ahr -/mice. Macrophages were subjected to pro-inflammatory stimuli (LPS + IFN-γ) and treated with pelargonidin for 16 h. Stimulation with LPS + IFN-γ induced an increase in the production of pro-inflammatory cytokines ( Figure 4A , B) and a reduction in the production of Tgf-β ( Figure 4C ) in macrophages deriving from both genotypes. Il-6 up-regulation was much higher in Ahr -/macrophages compared to wild-type ( Figure 4E ). Treatment with pelargonidin reverted the pro-inflammatory polarization but only in wild-type macrophages, while it had no effect on Ahr -/macrophages, underlining the role of the AHR receptor in the mechanism of action of pelargonidin.

Taking into consideration obesity pandemia and that exposure to high caloric intake promotes a state of intestinal sub-inflammation, and that obesity is a welldefined risk factor for development of severe COVID19, we have first tested the effects of pelargonidin in a mouse model of a high-fat/high-sugar diet [39] [40] [41] .

In this model, Ahr +/+ and Ahr -/mice were treated with exposed a chronic high caloric [26] intake by feeding them a diet enriched cholesterol and fructose (HFD-F) for 8 weeks. Starting from the second week (day 8) an experimental group of mice for each genotype was treated with pelargonidin daily. As shown in Figure 5 , mice exposed to chronic high caloric intake gained significantly more body weight than mice feed a normal chow diet, and they had significantly higher BMI at the end of the study without significant differences between the two genotypes ( Figure 5A -C). Treating mice with 5 mg/kg/day pelargonidin for 7 weeks protected against body weight gain and resulted in a lower BMI in comparison to mice feed an HFD-F alone ( Figure 5A -C). Instead, the beneficial effects exerted by pelargonidin were completely abrogated in Ahr -/mice ( Figure 5A-C) . We have therefore focused our attention on intestinal inflammation. The histological analysis of the colon showed no major morphological abnormalities, although further functional assessment revealed a robust increase of intestinal permeability in the mice exposed to HFD-F ( Figure 5D , E). Treating mice with pelargonidin restored the normal colon permeability in wildtype mice, but had no beneficial effects in Ahr-/-mice which exhibited much more severe changes in permeability than in Ahr +/+ mice ( Figure 5D , E).

Elevated colonic ACE2 levels have been detected in the colon of IBD patients and are associated with inflammation and severe disease, suggesting a possible correlation between Ace2 expression and colon inflammation in IBD patients [12] . We have therefore investigated the expression of Ace2 and Mas in the colon and compared them with colon profiles of various cytokines ( Figure 5F -J). HFD-F increased Ace2 expression and reduced Mas expression in both Ahr +/+ and Ahr -/mice, while increased the colon expression of Il-1β and Tnf-α and downregulated the Tgf-β mRNA.

Pelargonidin treatment reversed the inflammatory pattern by down-regulating the expression of both Il-1β and Tnf-α, but only in Ahr +/+ mice. In wild-type mice exposure to the anthocyanin also reduced the expression of Ace2, bringing it back to the value measured in untreated wild-type mice, while exerted only a slight effect on the expression of Mas mRNA ( Figure 2F -J). To investigate whether there was also in this mouse models with a mild inflammation in the colon, a direct correlation between the expression of Ace2 and pro-inflammatory cytokines, we performed correlation analyses between Il-1β and Ace2 and between Tnf-α and Ace2. As shown in Figure 5K and L, the colon levels of the two cytokines were positively correlated with Ace2 expression in both Ahr +/+ and Ahr -/mice. The fact that the R squared value was greater in the Tnf-α/Ace2 correlation than Il-1β/Ace2 confirmed a stronger correlation between the expression of Ace2 and Tnf-α.

Because, ACE2 expression in the intestine is highly restricted to epithelial cells, we have then examined whether exposure of Caco-2 cells, a human intestinal epithelial cell line, to TNF-α modulates the expression of ACE2. The results of these experiments demonstrated that exposure to TNF-α promotes the expression of pro-inflammatory cytokines Il-6 and Il-1β by Caco-2 cells (Figure 6B , C) and increased the expression of Ace2 (≈2.5 times) confirming the close correlation between TNF-α and Ace2 ( Figure 6A ). Administration of pelargonidin reversed this pattern in a concentration-dependent manner ( Figure 6A-C) .

Since ACE2 represents the host receptor used by the SARS-Cov2 virus to invade cells, and reducing the expression of ACE2 might represent an interesting host defense mechanism against virus invasion. In this context we also investigated whether pelargonidin was able to reduce the binding of the viral Spike protein on ACE2 (Figure 7) .

We therefore investigated, through docking calculations, the possibility of pelargonidin to bind several pockets suggested in previous studies: i) the hydrophobic pockets on the -sheet core of the RBD [42] , ii) the fatty acid (FA) pocket identified by Toelzer et al. [33, 43] . and finally, iii) the flavonoids binding pocket suggested by Allam et al. [44] . All docking calculations were performed using Glide software package. The scores of the best poses highlighted a marked preference of the results obtained in the FA pocket (best docking score -7.7 kcal/mol), with respect to the results obtained in the hydrophobic pockets on the -sheet core of the RBD (best docking score -5.2 kcal/mol) or in the pocket proposed by Allam (best docking score -5.8 kcal/mol), thus suggesting that pelargonidin binds the FA pocket on the RBD of Spike, as already reported for other highly unsaturated naturally occurring compounds (e.g. Vitamin k, retinoids) [43] . Analysis of the best scored and clustered docking pose in the FA pocket ( Figure 7A-C) showed the pelargonidin polyphenolic ring contacting with Leu368, Leu387, Phe388, Phe342 and Ile434. Furthermore, Phe377 makes a -cation interaction with the oxygen of the ring C, whereas Tyr365 and Tyr369 are engaged in a - stacking with the biphenyl ring and with the ring B, respectively. Finally, the binding mode is further stabilized by the H-bond formed between the ring B hydroxyl group and the backbone of Ala372.

Given the results of the docking calculations, we have then investigated whether the pelargonidin impact on the binding of S protein to the ACE2 receptor. For this purpose, a Spike/ACE2 Inhibitor Screening Assay Kit was used.

The results obtained by us showed that pelargonidin was able to reduce binding in a concentration-dependent manner. At the highest tested concentration, equal to 50 μM, we measured a reduction in Spike binding on ACE2 of about 40% ( Figure 7D ). To confirm this data, we also performed a SARS-CoV-2 virus infection test on Vero E6 cell line, kidney epithelial cells extracted from monkey. In this assay, pelargonidin showed an ability to reduce virus entry, measured by plaque assay, of approximately 30% ( Figure 7E ).

The data obtained from docking and in vitro tests associated with the downregulation of Ace2 expression exerted by pelargonidin and the anti-inflammatory activity make pelargonidin very interesting in the prevention and treatment of SARS-Cov-2 infection.

Recent data suggest that colon inflammation up-regulates the expression of Ace2. Studies of IBD patients have shown that a direct correlation exists between the severity of colon inflammation and the expression of ACE2 [12, 13, 45] .

These data are consistent with previous findings [10, 46] demonstrating that ACE2 gene expression is increased in human bronchial epithelial cells infected by SARS-CoV-2 as a response to inflammatory cytokine stimulation including interferon IFNγ. In the colon of patients with active IBD several pro-inflammatory cytokines like IFN-γ, TNFα, IL-1, and IL-6 are up-regulated [47] . In line with these data, we wanted to investigate the correlation between pro-inflammatory cytokine expression and Ace2 expression in the colon in a mouse models of IBD and mouse model of high caloric intake. Obesity is a clinical condition with a high prevalence in the most industrialized countries and it is now known that it involves a state of subinflammation in the gastrointestinal tract [48, 49] and it is a well-defined risk factor for develop severe COVID19.

ACE2 represents the host receptor used by the SARS-Cov2 virus to invade cells. Two recent studies [50, 51] have shown that the virus might infect the human gut, and therefore the modulation of Ace2 expression in the gastrointestinal tract represents an interesting research area. The data we have obtained in the two mouse models of intestinal inflammation strongly support the notion that upregulation of ACE2 in colon is due to the induction of state of inflammation characterized by strong induction of expression of pro-inflammatory cytokines. Importantly, in contrast to ACE2 the expression of the Ang 1-7 receptor Mas, was markedly downregulated in these models (Figure 3 and 5) . In the TNBS model the levels of colon cytokine were increased by 5-20 folds and the expression of ACE2 mRNA was induced by ≈7-fold in comparison to naive mice ( Figure 3E ). The state of mild inflammation present in the colon of mice fed with HFD-F induces an increase in the expression of Il-1β and Tnf-α by 2 times, while the expression of Tgf-β was markedly reduced ( Figure 5H-J) . Moreover, in the colon of animals subjected to a high-calorie diet, the expression of ACE2 doubled while that of MAS was halved when compared to that in mice fed a chow-diet ( Figure 5F , G). These data establish a direct correlation between the severity of inflammation and ACE2 gene transcription.

In both mouse models we have found that values of R squared indicated a close correlation between the expression of Ace2 and the pro-inflammatory cytokine Tnfα. These data are in agreement with the reducing effect on ACE2 expression in the colon of IBD patients exerted by therapy with anti-TNF-α [12, 52] . Confirmation of the direct regulation of ACE2 expression exerted by TNF-α was given by the in vitro experiment on human intestinal epithelial cell line (Caco-2). Indeed, the data obtained by us showed that the exposure of intestinal epithelial cells to TNF-α is able to up-regulate the expression of ACE2 ( Figure 6A) .

Similarly, to other flavonoids, pelargonidin, a common constituent of many red plant foods, including berries, grapes or cabbage, have been used in the traditional medicine in the treatment of a number of human alignments [53, 54] .

Pelargonidin display a several biological activities, the most prominent being those related to their anti-oxidant effects. We have confirmed in this study that pelargonidin exerts anti-inflammatory effects in intestines in mouse models of IBD and obesity through the interaction with the AhR. Treatment with pelargonidin reduced the expression of pro-inflammatory cytokines in the colon in both models of intestinal inflammation, alleviating the disease (Figure 2, 3 and 5) . Furthermore, treatment with pelargonidin restored ACE2 expression to the level measured in the colon of naive mice ( Figure 3E and Figure 5F ). The beneficial effects exerted by the compound were abrogated in the absence of AhR confirming the functional relevance of the receptor in mediating the anti-inflammatory activities of this flavonoid (Figure 4, 5) . In vitro studies also confirmed that pelargonidin might directly inhibit ACE2 induction caused by exposure of human intestinal epithelial cell line to the TNF-α ( Figure 6 ).

The regulatory effects of pelargonidin on the intestinal ACE2 might be of relevance in the context of SARS-CoV2 infection, since high levels of ACE2 are compatible with an increased risk of SARS-CoV2 uptake by the inflamed colon [12] .

Importantly, in addition to ACE2 regulation, we have shown that beneficial effects of pelargonidin might extend to a direct regulation of SARS-CoV2/ACE2 interaction.

Indeed, we found that pelargonidin not only reduces the interaction between ACE2 and the Spike protein of the SARS-Cov-2 but also reduces the ability of the SARS-CoV-2 to infect Vero E6 cell line, a monkey kidney epithelial cell line used to investigate the SARs-CoV2 replication (Figure 7) . We have investigated the molecular mechanisms involved in preventing the binding of SARS-CoV2 virus to its receptor identifying the fatty acid binding pocket in the RBD as the putative binding site of pelargonidin.

In summary (Figure 8 ) we shown that the natural flavonoid, pelargonidin, reverses ACE2 induction in rodent models of inflammation and this effect is mediated by AhR. In addition, the pelargonidins might reduce SARS-CoV2/ACE2 interaction affecting the virus uptake and replication. These data highlight the potential of natural agents in reducing inflammation. Pelargonidin exerts a protective effect with an Ahr-dependent and an Ahr-independent mechanism. The compound activates the Ahr receptor which blocks NF-kB translocation into the nucleus by sequestering the RelA subunit and thereby inhibiting the expression of Ace2.

Pelargonidin also directly inhibits the binding of the SARS-Cov-2 virus to the ACE2 receptor. This double action, together with the anti-inflammatory activity, inhibits the entry of the virus into cells.

A Novel Coronavirus from Patients with Pneumonia in China

Structural basis for the recognition of SARS-CoV-2 by fulllength human ACE2

Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains

Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion

Veesler D: Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19

Expression of SARS-CoV-2 entry factors in lung epithelial stem cells and its potential implications for COVID-19

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

Digestive symptoms of COVID-19 and expression of ACE2 in digestive tract organs

Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease

Increased Colonic Expression of ACE2 Associates with Poor Prognosis in Crohn's disease

Reduced expression of COVID-19 host receptor, ACE2 is associated with small bowel inflammation, more severe disease, and response to anti-TNF therapy in Crohn's disease

Intestinal receptor of SARS-CoV-2 in inflamed IBD tissue seems downregulated by HNF4A in ileum and upregulated by interferon regulating factors in colon

The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients

Aryl hydrocarbon receptor and intestinal immunity

Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor

AHR Function in Lymphocytes: Emerging Concepts

Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target? Gut 2020

ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation

Compositional and Functional Properties of Saskatoon Berry and Blueberry

Higher anthocyanin intake is associated with lower arterial stiffness and central blood pressure in women

Preventive and therapeutic effects of blueberry (Vaccinium corymbosum) extract against DSS-induced ulcerative colitis by regulation of antioxidant and inflammatory mediators

Bilberry-Derived Anthocyanins Modulate Cytokine Expression in the Intestine of Patients with Ulcerative Colitis

The Aryl Hydrocarbon Receptor (AhR) Mediates the Counter-Regulatory Effects of Pelargonidins in Models of Inflammation and Metabolic Dysfunctions

The Bile Acid Receptor GPBAR1 Regulates the M1/M2 Phenotype of Intestinal Macrophages and Activation of GPBAR1 Rescues Mice from Murine Colitis

BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis

A guide to histomorphological evaluation of intestinal inflammation in mouse models

Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature

Two Detailed Plaque Assay Protocols for the Quantification of Infectious SARS-CoV-2

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein

Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments

Epik: a software program for pK( a ) prediction and protonation state generation for drug-like molecules

A globally convergent version of the Polak-Ribière conjugate gradient method

Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening

Integrated Modeling Program, Applied Chemical Theory (IMPACT)

COVID-19 and the role of chronic inflammation in patients with obesity

The role of obesity in inflammatory markers in COVID-19 patients

Body mass index and risk of infections: a Mendelian randomization study of 101,447 individuals

Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain

Molecular Simulations suggest Vitamins, Retinoids and Steroids as Ligands of the Free Fatty Acid Pocket of the SARS-CoV-2 Spike Protein*

An in silico perception for newly isolated flavonoids from peach fruit as privileged avenue for a countermeasure outbreak of COVID-19

Age, Inflammation, and Disease Location Are Critical Determinants of Intestinal Expression of SARS-CoV-2 Receptor

Increasing host cellular receptorangiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection

COVID-19 and immunomodulation in IBD

Role of intestinal inflammation as an early event in obesity and insulin resistance

Interaction of obesity and inflammatory bowel disease

Infection of bat and human intestinal organoids by SARS-CoV-2

SARS-CoV-2 productively infects human gut enterocytes

Down-Regulation of Colonic ACE2 Expression in Patients With Inflammatory Bowel Disease Responding to Anti-TNF Therapy: Implications for COVID-19

Therapeutic potential of flavonoids in inflammatory bowel disease: A comprehensive review

Extensive review of popular functional foods and nutraceuticals against obesity and its related complications with a special focus on randomized clinical trials